Nuclear Medicine Imaging Equipment Market Projected to Exceed $2 Billion by 2010, According to New Report by Global Industry Analysts, Inc.

Share Article

Healthcare reforms, procedure volumes and technological advancements are the key factors impacting market growth. The worldwide nuclear medicine imaging equipment market is projected to exceed US$2 billion by 2010.

Nuclear Medicine: A Global Strategic Business Report

Nuclear medicine facilitates accurate diagnoses of cardiac diseases, blood flow blockages, neurological disorders, and dysfunction of any major body/organ. Gamma Cameras and PET Scanners are the primary imaging devices used for nuclear medicine procedures. Though nuclear medicine faces competition from other methods, their impact is limited. Demand for diagnostic medical imaging modalities is closely interlinked to the number of diagnostic procedures. Growing awareness of PET's clinical utility and its synergistic use with other imaging modalities and ongoing shift to PET-CT imaging and SPECT-CT imaging is one of the key reasons driving the dramatic rise in procedural volumes. In addition, advancements in molecular imaging, evolution of image-guided interventions, as well as aging population continue to fuel growth in the broader medical diagnostics market. The market is also significantly impacted by changes in reimbursement policies and third party insurers.

The United States is the largest market for nuclear medicine equipment worldwide, worth an estimated US$1.2 billion in 2007 as stated by Global Industry Analysts, Inc. Europe is the second largest regional market followed by Japan at third position. Japan, US and Europe collectively account for over 90 percent of the global nuclear medicine market. The global and regional markets are expected to register CAGRs ranging between 5% and 10%. The market for gamma cameras is estimated at US$813 million in 2007, while the PET Scanner market is expected to reach US$1.12 billion in 2009.

The global marketplace is relatively characterized by the presence of niche as well as well-established players. Market participants include Digirad, GE Healthcare, IS2 Medical Systems, Molypharma, Orbotech Medical Solutions, Philips Medical Systems, Positron, Siemens Medical, Tyco Healthcare and Toshiba.

"Nuclear Medicine: A Global Strategic Business Report" published by Global Industry Analysts, Inc., provides a comprehensive review of market trends, drivers, product profile, players, competitive landscape, technological developments, recent developments, mergers, acquisitions, and other strategic industry activities. Analysis is presented for major geographic markets such as United States, Japan, France, Germany, the UK, Italy, Spain, Asia, and rest of world. Analytics are provided in terms of product segments including Gamma Cameras and PET Scanners.

For more details about this research report, please visit http://www.strategyr.com/Nuclear_Medicine_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press@StrategyR.com
Web Site http://www.StrategyR.com

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website